Literature DB >> 20205675

Serum albumin concentration and cognitive impairment.

D J Llewellyn1, K M Langa, R P Friedland, I A Lang.   

Abstract

Results from clinical samples suggest low serum albumin may be associated with cognitive impairment, though evidence from population-based studies is inconclusive. Participants were 1,752 adults (699 men and 1,053 women) aged 65 years and over from the Health Survey for England 2000, a nationally representative population-based study. Cognitive impairment was assessed using the Abbreviated Mental Test Score. The cross-sectional relation of serum albumin quartiles to cognitive impairment was modelled using logistic regression. Two hundred and twelve participants were cognitively impaired (68 men and 144 women). Odds ratios (95% confidence intervals) for cognitive impairment in the first (2.2-3.8 g/dl), second (3.9-4.0 g/dl), and third (4.1-4.3 g/dl) quartiles of serum albumin compared with the fourth (4.4-5.3 g/dl) were 2.5 (1.3-5.1), 1.7 (0.9-3.5), and 1.5 (0.7-2.9), after adjustment for age, sex, education and additional risk factors for cognitive impairment (p for linear trend = 0.002). A highly similar pattern of associations was observed for men and women. Our data provide new evidence to suggest that low serum albumin is independently associated with increased odds of cognitive impairment in the elderly population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205675      PMCID: PMC2886725          DOI: 10.2174/156720510790274392

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  29 in total

1.  The abbreviated mental test: its use and validity.

Authors:  S Jitapunkul; I Pillay; S Ebrahim
Journal:  Age Ageing       Date:  1991-09       Impact factor: 10.668

Review 2.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 3.  The antioxidant properties of serum albumin.

Authors:  Marjolaine Roche; Philippe Rondeau; Nihar Ranjan Singh; Evelyne Tarnus; Emmanuel Bourdon
Journal:  FEBS Lett       Date:  2008-05-12       Impact factor: 4.124

4.  Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

Authors:  M Maes; N DeVos; A Wauters; P Demedts; V W Maurits; H Neels; E Bosmans; C Altamura; A Lin; C Song; M Vandenbroucke; S Scharpe
Journal:  J Psychiatr Res       Date:  1999 Sep-Oct       Impact factor: 4.791

5.  Evaluation of a mental test score for assessment of mental impairment in the elderly.

Authors:  H M Hodkinson
Journal:  Age Ageing       Date:  1972-11       Impact factor: 10.668

6.  CSF and serum concentrations of albumin and IgG in Alzheimer's disease.

Authors:  A D Kay; C May; N M Papadopoulos; R Costello; J R Atack; J S Luxenberg; N R Cutler; S I Rapoport
Journal:  Neurobiol Aging       Date:  1987 Jan-Feb       Impact factor: 4.673

7.  Albumin protects human red blood cells against Abeta25-35-induced lysis more effectively than ApoE.

Authors:  Luciano Galeazzi; Roberta Galeazzi; M Beatrice Valli; Elizabeth H Corder; Sergio Giunta
Journal:  Neuroreport       Date:  2002-11-15       Impact factor: 1.837

8.  Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Nicoletta Brunetti; Mabel Martelli; Lucia Servadei; Luciana Bastagli; Marisa Bianchin; Erminia Mariani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-08       Impact factor: 6.053

9.  Serum albumin levels predict cognitive impairment in elderly hip fracture patients.

Authors:  Eliyahu Hayim Mizrahi; Tzvia Blumstein; Marina Arad; Abraham Adunsky
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008-01-03       Impact factor: 2.035

10.  Albumin, haemoglobin, BMI and cognitive performance in older adults.

Authors:  Te-Pin Ng; Lei Feng; Mathew Niti; Keng Bee Yap
Journal:  Age Ageing       Date:  2008-05-20       Impact factor: 10.668

View more
  32 in total

1.  Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

Authors:  Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

2.  Aβ association inhibition by transferrin.

Authors:  Annie V Raditsis; Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

3.  Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.

Authors:  Jing Wang; Xialin Chen; Weirong Bai; Zhenzhong Wang; Wei Xiao; Jingbo Zhu
Journal:  Neurochem Res       Date:  2021-05-14       Impact factor: 3.996

4.  Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.

Authors:  Gajanan Sathe; Chan Hyun Na; Santosh Renuse; Anil K Madugundu; Marilyn Albert; Abhay Moghekar; Akhilesh Pandey
Journal:  Proteomics Clin Appl       Date:  2019-01-25       Impact factor: 3.494

5.  Development and validation of risk index for cognitive decline using blood-derived markers.

Authors:  Jasmine Nettiksimmons; Hilsa Ayonayon; Tamara Harris; Caroline Phillips; Caterina Rosano; Suzanne Satterfield; Kristine Yaffe
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

6.  Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states.

Authors:  Moustafa Algamal; Rashik Ahmed; Naeimeh Jafari; Bilal Ahsan; Joaquin Ortega; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

7.  Methamphetamine-Induced Cognitive Deficits and Psychiatric Symptoms Are Associated with Serum Markers of Liver Damage.

Authors:  Tingting Zhao; Changping Zhai; Hongmei Song; Yanhai Wu; Chuanhui Ge; Yonglin Zhang; Hongxia Xu; Zhengsuo Chi; Hui Chu; Wei Shi; Xiaodong Cheng; Xin Li; Mengdi Ma; Mengyuan Xu; Jiaqi Hu; Ya Xie; Yanan Lin; Hongxu Chen; Yiting Li; Dongliang Jiao
Journal:  Neurotox Res       Date:  2019-11-05       Impact factor: 3.911

8.  Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.

Authors:  Jyoti Barokar; Allen McCutchan; Reena Deutsch; Bin Tang; Mariana Cherner; Ajay R Bharti
Journal:  J Neurovirol       Date:  2019-07-07       Impact factor: 2.643

9.  Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics.

Authors:  Rebecca K West; Ramit Ravona-Springer; Abigail Livny; Anthony Heymann; Danit Shahar; Derek Leroith; Rachel Preiss; Ruth Zukran; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-04-23       Impact factor: 6.053

10.  Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.

Authors:  Moustafa Algamal; Julijana Milojevic; Naeimeh Jafari; William Zhang; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.